Extract

The primary objective of the study is to evaluate HBsAg loss and seroconversion in subjects who stop tenofovir disoproxil fumarate (TDF) (Arm A) compared to subjects who continue TDF (Arm B)

Inclusion criteria

• Chronic hepatitis B

Links

• ictrp
• euctr